The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SNYR | -68.42% | +352.88% | +35.27% | -92% |
| S&P | +14.11% | +87.98% | +13.46% | +267% |
Synergy CHC Corp., a consumer health care company, markets and distributes various consumer branded products primarily in the health and wellness industry in North America. The company offers FOCUSfactor, a brain-health nutritional supplement that includes a blend of brain supporting vitamins, minerals, antioxidants, and other nutrients, Flat Tummy Tea, a two-step herbal detox tea that works to help speed metabolism, boost energy, and reduce bloating, and Hand MD, an anti-aging skincare line formulated for the hands. It also provides Neuragen, a topical product that works directly at the site of the pain as opposed to oral products, Sneaky Vaunt, a backless, strapless, stick on, and push up bra, The Queen Pegasus, a two-step eyelash elixir kit for natural eyelashes, the Per-fekt Beauty line of cosmetics, and Think Fuel, a nootropic supplement to enhance brain function. It sells its products directly to wholesalers and distributors, and online through flattummyco.com, sneakyvaunt.com, thequeenpegasus.com, perfektbeauty.com, and www.thinkfuel.com, as well as through retail distribution channels. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $8.01M | 12.4% |
| Gross Profit | $5.65M | 18.7% |
| Gross Margin | 70.50% | 3.8% |
| Market Cap | $27.31M | 1707.7% |
| Market Cap / Employee | $1.30M | 0.0% |
| Employees | 21 | 0.0% |
| Net Income | $0.13M | -84.0% |
| EBITDA | $1.31M | 21.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.11M | 207.9% |
| Accounts Receivable | $6.81M | 67.3% |
| Inventory | 2.1 | 12.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $25.11M | 31.6% |
| Short Term Debt | $0.00M | -100.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 15.71% | 0.0% |
| Return On Invested Capital | -109.94% | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2.31M | -872.5% |
| Operating Free Cash Flow | -$2.31M | -872.5% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 2.41 | 2.10 | 7.68 | 8.36 | - |
| Price to Book | -1.52 | -1.21 | -1.56 | -1.86 | - |
| Price to Sales | 1.08 | 0.60 | 0.76 | 0.71 | - |
| Price to Tangible Book Value | -1.50 | -1.19 | -1.54 | -1.83 | - |
| Enterprise Value to EBITDA | 46.21 | 24.23 | 30.63 | 37.06 | -22.68% |
| Total Debt | $27.52M | $28.12M | $26.87M | $25.11M | -21.52% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
